Plasma-based Colorectal Cancer Screening Research & Development
Clinical Sample Protocol for Plasma-based Colorectal Cancer Screening Research & Development
Sponsor: Epigenomics, Inc
Listed as NCT04027790, this observational or N/A phase trial focuses on Colo-rectal Cancer and remains completed. Sponsored by Epigenomics, Inc, it has been updated 11 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Mar 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Aug 2019 — Jan 2020 [monthly]
Recruiting
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Epigenomics, Inc
For direct contact, visit the study record on ClinicalTrials.gov .